These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 115540)

  • 41. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
    Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
    Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ergometric control in hypertension treatment with labetalol].
    Prohaska H; Honetz N
    Wien Med Wochenschr Suppl; 1981; 69():20-2. PubMed ID: 6952661
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E; Kristensen BO
    Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Labetalol in ambulatory therapy of hypertension].
    Zilcher H; Weber H; Glogar D
    Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656
    [No Abstract]   [Full Text] [Related]  

  • 45. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

  • 46. [Lichenoid cutaneous eruptions caused by labetalol].
    Bertani E; Sala F; Crosti C; Terragni L
    G Ital Dermatol Venereol; 1982; 117(4):229-32. PubMed ID: 6227554
    [No Abstract]   [Full Text] [Related]  

  • 47. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Aphthoid stomatitis induced by labetalol].
    Pradalier A; Dry J; Baron JF
    Therapie; 1982; 37(6):695-7. PubMed ID: 7167874
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
    McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term use of labetalol.
    Bailey RR
    N Z Med J; 1982 Dec; 95(722):897. PubMed ID: 6962390
    [No Abstract]   [Full Text] [Related]  

  • 51. Cutaneous reactions to labetalol.
    Br Med J; 1978 Apr; 1(6118):987. PubMed ID: 147722
    [No Abstract]   [Full Text] [Related]  

  • 52. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
    Tcherdakoff P
    Pharmatherapeutica; 1983; 3(5):342-8. PubMed ID: 6844370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Side effects of labetalol in newborn infants.
    Woods DL; Malan AF
    Br J Obstet Gynaecol; 1983 Sep; 90(9):876. PubMed ID: 6615747
    [No Abstract]   [Full Text] [Related]  

  • 55. Labetalol-induced toxic myopathy.
    Teicher A; Rosenthal T; Kissin E; Sarova I
    Br Med J (Clin Res Ed); 1981 Jun; 282(6279):1824-5. PubMed ID: 6786636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Labetalol for hypertension.
    Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747
    [No Abstract]   [Full Text] [Related]  

  • 57. [Labetalol in resistant hypertension].
    Stern N; Teicher A; Rosenthal T
    Harefuah; 1981 Aug; 101(3-4):54-6. PubMed ID: 7319385
    [No Abstract]   [Full Text] [Related]  

  • 58. Life-threatening hyperkalemia after intravenous labetolol injection for hypertensive emergency in a hemodialysis patient.
    Hamad A; Salameh M; Zihlif M; Feinfeld DA; Carvounis CP
    Am J Nephrol; 2001; 21(3):241-4. PubMed ID: 11423696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Labetalol for hypertension.
    Drug Ther Bull; 1978 Nov; 16(23):89-90. PubMed ID: 699758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.